Related Experiment Video
Updated: Jan 26, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
Reproducible pharmacokinetics
1Departments of Medicine, Health Research and Policy, Biomedical Data Science, and Statistics, Stanford Prevention Research Center, Meta-Research Innovation Center at Stanford (METRICS), Stanford University, 1265 Welch Road, Medical School Office Building Room X306, Stanford, CA, 94305, USA. jioannid@stanford.edu.
Improving reproducibility in pharmacokinetic research is crucial. This involves addressing issues like limited adoption of reporting standards, methodological quality, and publication bias to enhance scientific rigor.
Area of Science:
- Pharmacokinetics
- Scientific Reproducibility
- Biostatistics
Background:
- Reproducibility is a critical aspect of scientific research, particularly in pharmacokinetics, a field with extensive publication volume.
- Distinguishing true biological variability from errors is essential for reliable pharmacokinetic parameter interpretation.
- Existing efforts to improve reproducibility face challenges in widespread adoption and consistent implementation.
Purpose of the Study:
- To review current challenges and propose solutions for enhancing reproducibility in pharmacokinetic studies.
- To identify areas for improvement in reporting standards, methodological rigor, and data transparency.
- To discuss the impact of biases, such as publication bias, on pharmacokinetic research.
Main Methods:
- Literature review of existing guidance documents and empirical studies on pharmacokinetic research quality.
- Analysis of adoption rates for proposed standards and pre-registration practices.
- Examination of factors contributing to heterogeneity in pharmacokinetic parameters.
Main Results:
- Limited adoption of proposed reporting and research guidance documents for pharmacokinetic studies.
- Identified quality issues in methods and model evaluations within the literature.
- Low rates of pre-registration for pharmacokinetic studies and potential for significant unpublished research (publication bias).
Conclusions:
- Standardization of statistical and laboratory tools, alongside improved reporting, is necessary.
- Addressing publication bias and increasing the use of meta-analyses are key opportunities.
- Enhancing transparency through data and protocol sharing can significantly improve pharmacokinetic research reproducibility.
Related Concept Videos
Pharmacokinetics: Overview
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinear Pharmacokinetics: Causes of Nonlinearity
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Biopharmaceutics and Pharmacokinetics: Overview
Cholinergic Antagonists: Pharmacokinetics

